Discordant results in Tc-99m tetrofosmin and Tc-99m sestamibi parathyroid scintigraphies

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 7, 2007, Pages 1166-1168

  Duarte, Paulo Schiavom ^a   Domingues, Fernanda C ^a   Costa, Michele Santi ^a   Brandão, Cynthia ^a   De Oliveira, Marco A C ^a   Vieira, José G H ^a  

^a Fleury   (Brazil)

Author keywords

MIBI; Parathyroid; Scintigraphy; Sestamibi; Tetrofosmin

Indexed keywords

EID: 38149140311     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302007000700021     Document Type: Article

References (16)

1. Carty SE, Worsey J, Virji MA, Brown ML, Watson CG. Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery 1997;122:1107-14.
2. Casas AT, Burke GJ, Mansberger AR Jr., Wei JP. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 1994;60:12-6.
3. Irvin GL III, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SK. A new approach to parathyroidectomy. Ann Surg 1994;219:574-9.
4. Aigner RM, Fueger GF, Nicoletti R. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies. Eur J Nucl Med 1996;23:693-6.
5. Fjeld JG, Erichsen K, Pfeffer PF, Clausen OP, Rootwelt K. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. J Nucl Med 1997;38:831-4.
6. Gallowitsch HJ, Mikosch P, Kresnik E, Gomez I, Lind P. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Invest Radiol 1997;32:459-65.
7. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998;39:320-4.
8. Mansi L, Rambaldi PF, Marino G, Pecori B, Del Vecchio E. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma. Clin Nucl Med 1996;21:700-3.
9. Vallejos V, Martin-Comin J, Gonzalez MT, Rafecas R, Munoz A, Fernandez A, et al. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands. Clin Nucl Med 1999;24:959-64.
10. Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI, and US. Eur J Nucl Med 2001;28:1817-27.
11. Giordano A, Meduri G, Marozzi P, Rubini G, Burroni L, Cappagli M. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects. Nucl Med Commun 2003;24:321-6.
12. Harrell RM, Mackman DM, Bimston DN. Nonequivalent results of tetrofosmin and sestamibi imaging of parathyroid tumors. Endocr Pract 2006;12:179-82.
13. Duarte PS, Decker HH, Aldighieri FC, Brandão C, Alonso G, Vieira JG. The relation between serum levels of calcium and PTH and the positivity of parathyroid scintigraphy with sestamibi - analysis of 194 patients. Arq Bras Endocrinol Metab 2005;49:930-7.
14. Sousa CA, Duarte PS, Pereira JC. Fuzzy logic and logistic regression in the decision making for parathyroid scintigraphy study. Rev Saúde Pública 2006;40:898-906.
15. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m- tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-6.
16. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m- tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266-71.